Home » Topics » BioWorld Science

BioWorld Science
RSS

Exicure provides updated interim data from phase Ib/II study of cavrotolimod

Aug. 6, 2021

Enrollment begins in phase II study of Stemedica's itMSCs in patients with COVID-19

Aug. 6, 2021

Aptahem reports positive preliminary results from GLP studies of Apta-1

Aug. 6, 2021

New thyroid hormone receptor agonists divulged by Eccogene

Aug. 6, 2021

Hisun Accuray Therapeutics, Zhejiang Hisun Pharmaceutical present SHP-2 inhibitors

Aug. 6, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent cereblon ligands

Aug. 6, 2021

Suzhou Zelgen Biosciences discovers G12C mutant GTPase KRAS inhibitors

Aug. 6, 2021

Enanta nominates EDP-235 as clinical candidate for the treatment of COVID-19

Aug. 6, 2021

Syros enters clinical supply agreement with Roche to evaluate SY-5609 as part of INTRINSIC study

Aug. 6, 2021

Positive phase II data published from GENETIC-AF study of bucindolol in patients with heart failure

Aug. 6, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...